| Abstrakt: |
In addition, in phase II (12mo after the withdrawal of atropine), there was no significant difference in AL change from the atropine group, when compared with that from the placebo group (0.31(+-)0.25 mm vs 0.28(+-)0.26 mm, P>0.05). Keywords: Atropine; Clinical Research; Clinical Trials and Studies; Eye Diseases and Conditions; Health and Medicine; Myopia; Ophthalmology; Refractive Errors; Tropanes EN Atropine Clinical Research Clinical Trials and Studies Eye Diseases and Conditions Health and Medicine Myopia Ophthalmology Refractive Errors Tropanes 1562 1562 1 06/12/23 20230612 NES 230612 2023 JUN 12 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- A new study on myopia is now available. [Extracted from the article] |
